Cyclosporin A in the treatment of severe atopic dermatitis and palmoplantar pustulosis

References

• Aliaga A, Armero F, Armijo M, et al. Sandimmun (ciclosporina A) en psoriasis crónica severa. Resultados del estudio multicéntrico español. Actas Dermosifiliogr 1994; 85: 381–5
   Google Scholar
• Ortuño Gil C, Sanchez Conejo-Mir J, Camacho F. Pio-derma gangrenoso de localizatión cefálica. Actas Dermosifiliogr 1991; 82: 797–9
   Google Scholar
• Camacho F, Sotillo I, Ciclosporina A. En Dermatologia. Monogr Dermatol 1995; 8: 381–97
   Google Scholar
• Camacho F, Mazuecos J. Avances en terapéutica dermatológica 1993. Monogr Dermatol 1994; 7: 211–35
   Google Scholar
• Witkamp L, Meinardi M M, Bossuyt P M, et al. A multicentre evaluation of the guidelines for the use of cyclosporine A in severe psoriasis. J Eur Acad Dermatol Venereol 1996; 7: 49–58
   Google Scholar
• Grossman R M, Chevret S, Abi-Rached J, et al. Long-term safety of cyclosporine in the treatment of psoriasis. Arch Dermatol 1997; 132: 623–9
   Google Scholar
• Mazer J M. Ciclosporine et psoriasis grave. Ann Dermatol Vénéréol 1996; 123: 280–4
   Google Scholar
• Shenefelt P D, Fenske N A. Management of severe pyoder-magangrenosum. Curr Opin Dermatol 1993; 1: 27–30
   Google Scholar
• Matis W L, Ellis C N, Griffiths C EM, Lazarus G S. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 1992; 128: 1060–4
   PubMed Web of Science ®Google Scholar
• Planagumà M, Puig L L, Garcia-Patos V, et al. Cyclosporine treatment of pyoderma gangrenosum. Eur J Dermatol 1992; 2: 249–52
   Google Scholar
• Martin de Hijas C, del Rio E, Gorospe M A, et al. Large periostomal pyoderma gangrenosum successfully treated with cyclosporine and corticosteroids. J Am Acad Dermatol 1993; 29: 1034–5
   Google Scholar
• Berth-Jones J, Graham-Brown R A, Marks R, et al. Long-term efficacy and safety of cyclosporine in severe adult atopic dermatitis. Br J Dermatol 1997; 136: 76–81
   PubMed Web of Science ®Google Scholar
• Reitamo S, Puska P, Lassus A. Cyclosporin in the treatment of palmoplantar pustulosis. Br J Dermatol 1989; 120: 857
   PubMed Web of Science ®Google Scholar
• Meinardi M MHM, de Rie M A, Bos J D. Oral cyclosporin A is effective in clearing persistent pustulosis palmaris et plantaris. Acta Derm Venereol (Stockh) 1990; 70: 77–81
   Google Scholar
• Bourke J F, Berth-Jones J, Holder J, Graham-Brown R AC. A new microemulsion formulation of cyclosporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses. Br J Dermatol 1996; 134: 777–9
   PubMed Web of Science ®Google Scholar
• Erkko P, Granlund H, Nuutinen M, Reitamo S. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis. Br J Dermatol 1997; 136: 82–8
   PubMed Web of Science ®Google Scholar
• Ely H. Recent developments in dermatologic uses of cyclosporine and amelioration of renal toxicity with pentoxifylline. Curr Opin Dermatol 1993; 1: 223–30
   Google Scholar
• Reitamo S, Erkko P, Remitz A, et al. Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study. Arch Dermatol 1993; 129: 1273–9
   PubMedGoogle Scholar
• Reitamo S, Erkko P, Remitz A. Palmoplantar pustulosis and cyclosporin A. J Dermatol Treat 1994; 5(Suppl 1)S16–S18
   Google Scholar
• Peter R U, Färber L, Weib J, et al. Low-dose cyclosporin A in palmoplantar psoriasis: evaluation of efficacy and safety. J Eur Acad Dermatol Venereol 1994; 3: 518–24
   Google Scholar
• Lavaroni G, Kokelj F. Hallopeau's acrodermatitis treated with cyclosporin A — a case report. J Dermatol Treat 1994; 5: 209–10
   Google Scholar
• Cecchi R, Bartolli L, Brunetti L, et al. CyA nella pustolosi palmo-plantare persistente (PPP). G Ital Dermatol Venereol 1995; 130(Suppl 1)19–20
   Google Scholar
• Yamamoto T, Kimura K, Katayama I, Nishioka K. Successful treatment of severe arthralgia associated with palmoplantar pustulosis with low-dose oral cyclosporine A. J Dermatol 1995; 22: 512–14
   Google Scholar
• Van Joost T, et al. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol 1994; 130: 634–40
   PubMed Web of Science ®Google Scholar
• Salek M S, Finlay A Y, Luscombe D K, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol 1993; 129: 422–30
   PubMed Web of Science ®Google Scholar
• Camp R DR, Reitamo S, Friedman P S, et al. Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop. April 1993. Br J Dermatol 1993; 129: 217–20
   PubMed Web of Science ®Google Scholar
• Munro C S, Levell N J, Shuster S, Friedmann P S. Maintenance treatment with cyclosporin in atopic eczema. Br J Dermatol 1994; 130: 376–80
   PubMed Web of Science ®Google Scholar
• Caputo R, Veraldi S. Treatment of adult atopic dermatitis with low-dose (3 mg/kg per day) cyclosporine. J Dermatol Treat 1996; 7: 3–6
   Web of Science ®Google Scholar
• Taylor M, Ashcroft A TT, Messenger A G. Cyclosporin A prolongs human hair growth in vitro. J Invest Dermatol 1993; 100: 237–9
   PubMedGoogle Scholar
• Wahlstrom E, Zamora J U, Teichman S. Improvement in cyclosporine-associated gingival hyperplasia with azithromycin therapy. New Engl J Med 1995; 332: 753–4
   PubMed Web of Science ®Google Scholar
• Olujohungbe A, Cox J, Hammon M D, Prentice H G. Ingrowing toenails and cyclosporin. Lancet 1993; 342: 1111
   Google Scholar
• Higgins E M, Hughes J R, Snowden S, Pembroke A C. Cyclosporin-induced periungual granulation tissue. Br J Dermatol 1995; 132: 829–30
   Google Scholar
• Bowen J RC, Sahi S. Cyclosporin induced colitis. BMJ 1993; 307: 484
   Google Scholar
• Trüeb R M, Schmid-Grendelmeier P. Purpura associated with cyclosporine A therapy. Eur J Dermatol 1996; 6: 29–30
   Google Scholar
• Papadavid E, Yell J, Ryan T J. Conjunctival oedema: a side-effect of cyclosporine and a consequence of obesity. Br J Dermatol 1997; 135: 146–7
   Google Scholar
• Misciali C, Peluso A M, Cameli N, Tosti A. Occurrence of alopecia areata in a patient receiving systemic cyclosporine A. Arch Dermatol 1996; 132: 843–4
   Google Scholar
• Yamamoto T, Katayama I, Nishioka K. Adenocarcinoma of the mouth in a patient with psoriasis under short-term cyclosporine therapy. Dermatology 1997; 193: 72–3
   Google Scholar
• Giacalone B, Mastroianni A, Ferraro C, et al. Linfoma B insorto nel corso di un trattamento ciclosporinico in un paziente affetto da psoriasi eritrodermica. G Ital Dermatol Venereol 1996; 131: 39–43
   Google Scholar
• Welge-Lüssen U C, Gerhartz H H. Late onset of neurotoxicity with cyclosporin. Lancet 1994; 343: 293
   Google Scholar